Negative autoregulation of RANKL and c-Src signaling in osteoclasts

Journal of Bone and Mineral Metabolism

Volumn 25, Issue 4, 2007, Pages 205-210

  Yogo, Keiichiro ^a,b   Ishida Kitagawa, Norihiro ^a   Takeya, Tatsuo ^a  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b SHIZUOKA UNIVERSITY   (Japan)

Author keywords

Bone resorption; c Src; Osteoclasts; RANKL; SHIP

Indexed keywords

BETA INTERFERON; C SRC PROTEIN; CALCITONIN; INTERLEUKIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 1; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALBERS SCHOENBERG DISEASE; AUTOREGULATION; BONE MARROW; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BONE RESORPTION; DOWN-REGULATION; HUMANS; OSTEOCLASTS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RANK LIGAND; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 34347341662     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-007-0751-2     Document Type: Review

References (63)

1. DM Anderson E Maraskovsky WL Billingsley WC Dougall ME Tometsko ER Roux MC Teepe RF DuBose D Cosman L Galibert 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature (Lond) 390 175 179
2. BG Darnay V Haridas J Ni PA Moore BB Aggarwal 1998 Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase J Biol Chem 273 20551 20555
3. BR Wong R Josien SY Lee M Vologodskaia RM Steinman Y Choi 1998 The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor J Biol Chem 273 28355 28359
4. N Kim PR Odgren DK Kim SC Marks Jr Y Choi 2000 Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene Proc Natl Acad Sci U S A 97 10905 10910
5. J Li I Sarosi XQ Yan S Morony C Capparelli 2000 RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proc Natl Acad Sci U S A 97 1566 1571
6. A Naito S Azuma S Tanaka T Miyazaki S Takaki K Takatsu K Nakao K Nakamura M Katsuki T Yamamoto J Inoue 1999 Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice Genes Cells 4 353 362
7. MA Lomaga WC Yeh I Sarosi GS Duncan C Furlonger 1999 TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling Genes Dev 13 1015 1024
8. SL Teitelbaum FP Ross 2003 Genetic regulation of osteoclast development and function Nat Rev Genet 4 638 649
9. N Bucay I Sarosi CR Dunstan S Morony J Tarpley C Capparelli S Scully HL Tan W Xu DL Lacey WJ Boyle WS Simonet 1998 Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1260 1268
10. T Wada T Nakashima N Hiroshi JM Penninger 2006 RANKL-RANK signaling in osteoclastogenesis and bone disease Trends Mol Med 12 17 25
11. HC Blair LJ Robinson M Zaidi 2005 Osteoclast signalling pathways Biochem Biophys Res Commun 328 728 738
12. S Tanaka I Nakamura J Inoue H Oda K Nakamura 2003 Signal transduction pathways regulating osteoclast differentiation and function J Bone Miner Metab 21 123 133
13. N Ishida K Hayashi M Hoshijima T Ogawa S Koga Y Miyatake M Kumegawa T Kimura T Takeya 2002 Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator J Biol Chem 277 41147 41156
14. H Takayanagi S Kim T Koga H Nishina M Isshiki H Yoshida A Saiura M Isobe T Yokochi J Inoue EF Wagner TW Mak T Kodama T Taniguchi 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev Cell 3 889 901
15. N Ishida K Hayashi A Hattori K Yogo T Kimura T Takeya 2006 CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration J Bone Miner Res 21 48 57
16. M Asagiri K Sato T Usami S Ochi H Nishina H Yoshida I Morita EF Wagner TW Mak E Serfling H Takayanagi 2005 Autoamplification of NFATc1 expression determines its essential role in bone homeostasis J Exp Med 202 1261 1269
17. TN Crotti M Flannery NC Walsh JD Fleming SR Goldring KP McHugh 2006 NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation Gene (Amst) 372 92 102
18. M Matsumoto M Kogawa S Wada H Takayanagi M Tsujimoto S Katayama K Hisatake Y Nogi 2004 Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 J Biol Chem 279 45969 45979
19. Y Kim K Sato M Asagiri I Morita K Soma H Takayanagi 2005 Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis J Biol Chem 280 32905 32913
20. K Matsuo DL Galson C Zhao L Peng C Laplace KZQ Wang MA Bachler H Amano H Aburatani H Ishikawa EF Wagner 2004 Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos J Biol Chem 279 26475 26480
21. K Kim JH Kim J Lee HM Jin SH Lee DE Fisher H Kook KK Kim Y Choi N Kim 2005 Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis J Biol Chem 280 35209 35216
22. F Ikeda R Nishimura T Matsubara S Tanaka J Inoue SV Reddy K Hata K Yamashita T Hiraga T Watanabe T Kukita K Yoshioka A Rao T Yoneda 2004 Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation J Clin Invest 114 475 484
23. S Umeda WG Beamer K Takagi M Naito S Hayashi H Yonemitsu T Yi LD Shultz 1999 Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density Am J Pathol 155 223 233
24. K Aoki E Didomenico NA Sims K Mukhopadhyay L Neff A Houghton M Amling JB Levy WC Horne R Baron 1999 The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice Bone (NY) 25 261 267
25. HE Chen S Chang T Trub BG Neel 1996 Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1 Mol Cell Biol 16 3685 3697
26. Z Zhang E Jimi AL Bothwell 2003 Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis J Immunol 171 3620 3626
27. DB Stetson R Medzhitov 2006 Type I interferons in host defense Immunity 25 373 381
28. H Takayanagi S Kim K Matsuo H Suzuki T Suzuki K Sato T Yokochi H Oda K Nakamura N Ida EF Wagner T Taniguchi 2002 RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta Nature (Lond) 416 744 749
29. LF Coelho G Magno de Freitas Almeida FJ Mennechet A Blangy G Uze 2005 Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression Proc Natl Acad Sci U S A 102 11917 11922
30. H Zheng X Yu P Collin-Osdoby P Osdoby 2006 RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption J Biol Chem 281 15809 15820
31. T Hayashi T Kaneda Y Toyama M Kumegawa Y Hakeda 2002 Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation J Biol Chem 277 27880 27886
32. Becker KL, Müller B, Nylén ES, Cohen R, White JC, Snider RH Jr (2002) Calcitonin gene family of peptides: structure, molecular biology, and effects. In: vol 1, Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of Bone Biology, Academic Press, San Diego, pp 619-639
33. JP Woodrow CJ Sharpe NJ Fudge AO Hoff RF Gagel CS Kovacs 2006 Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation Endocrinology 147 4010 4021
34. P Jurdic F Saltel A Chabadel O Destaing 2006 Podosome and sealing zone: specificity of the osteoclast model Eur J Cell Biol 85 195 202
35. L Spinardi PC Marchisio 2006 Podosomes as smart regulators of cellular adhesion Eur J Cell Biol 85 191 194
36. SM Thomas JS Brugge 1997 Cellular functions regulated by Src family kinases Annu Rev Cell Dev Biol 13 513 609
37. N Kumagai K Ohno R Tameshige M Hoshijima K Yogo N Ishida T Takeya 2004 Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-kappaB and important for progression to multinucleated cell formation Biochem Biophys Res Commun 325 758 768
38. P Soriano C Montgomery R Geske A Bradley 1991 Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice Cell 64 693 702
39. C Lowe T Yoneda BF Boyce H Chen GR Mundy P Soriano 1993 Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts Proc Natl Acad Sci U S A 90 4485 4489
40. BF Boyce T Yoneda C Lowe P Soriano GR Mundy 1992 Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice J Clin Invest 90 1622 1627
41. PT Lakkakorpi I Nakamura M Young L Lipfert GA Rodan LT Duong 2001 Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts J Cell Sci 114 149 160
42. S Tanaka M Amling L Neff A Peyman E Uhlmann JB Levy R Baron 1996 c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption Nature (Lond) 383 528 531
43. LT Duong PT Lakkakorpi I Nakamura M Machwate RM Nagy GA Rodan 1998 PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase J Clin Invest 102 881 892
44. I Nakamura E Jimi LT Duong T Sasaki N Takahashi GA Rodan T Suda 1998 Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts J Biol Chem 273 11144 11149
45. A Sanjay A Houghton L Neff E DiDomenico C Bardelay E Antoine J Levy J Gailit D Bowtell WC Horne R Baron 2001 Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility J Cell Biol 152 181 195
46. T Miyazaki A Sanjay L Neff S Tanaka WC Horne R Baron 2004 Src kinase activity is essential for osteoclast function J Biol Chem 279 17660 17666
47. S Koga K Yogo K Yoshikawa H Samori M Goto T Uchida N Ishida T Takeya 2005 Physical and functional association of c-Src and adhesion and degranulation promoting adaptor protein (ADAP) in osteoclastogenesis in vitro J Biol Chem 280 31564 31571
48. M Chellaiah C Fitzgerald U Alvarez K Hruska 1998 c-Src is required for stimulation of gelsolin-associated phosphatidylinositol 3-kinase J Biol Chem 273 11908 11916
49. MA Chellaiah RS Biswas D Yuen UM Alvarez KA Hruska 2001 Phosphatidylinositol 3,4,5-trisphosphate directs association of Src homology 2-containing signaling proteins with gelsolin J Biol Chem 276 47434 47444
50. PT Lakkakorpi G Wesolowski Z Zimolo GA Rodan SB Rodan 1997 Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading Exp Cell Res 237 296 306
51. JE Damen L Liu P Rosten RK Humphries AB Jefferson PW Majerus G Krystal 1996 The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase Proc Natl Acad Sci U S A 93 1689 1693
52. MN Lioubin PA Algate S Tsai K Carlberg A Aebersold LR Rohrschneider 1996 p150Ship, a signal transduction molecule with inositol polyphosphate-5- phosphatase activity Genes Dev 10 1084 1095
53. LH Golden KL Insogna 2004 The expanding role of PI3-kinase in bone Bone (NY) 34 3 12
54. S Takeshita N Namba JJ Zhao Y Jiang HK Genant MJ Silva MD Brodt CD Helgason J Kalesnikoff MJ Rauh RK Humphries G Krystal SL Teitelbaum FP Ross 2002 SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts Nat Med 8 943 949
55. T Sugatani U Alvarez KA Hruska 2003 PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility J Biol Chem 278 5001 5008
56. K Yogo M Mizutamari K Mishima H Takenouchi N Ishida-Kitagawa T Sasaki T Takeya 2006 Src homology 2 (SH2)-containing 5′-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts Endocrinology 147 3307 3317
57. WC Horne A Sanjay A Bruzzaniti R Baron 2005 The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function Immunol Rev 208 106 125
58. WS Simonet DL Lacey CR Dunstan M Kelley MS Chang 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309 319
59. E Tsuda M Goto S Mochizuki K Yano F Kobayashi T Morinaga K Higashio 1997 Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis Biochem Biophys Res Commun 234 137 142
60. H Yasuda N Shima N Nakagawa SI Mochizuki K Yano N Fujise Y Sato M Goto K Yamaguchi M Kuriyama T Kanno A Murakami E Tsuda T Morinaga K Higashio 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endocrinology 139 1329 1337
61. H Takayanagi K Ogasawara S Hida T Chiba S Murata K Sato A Takaoka T Yokochi H Oda K Tanaka K Nakamura T Taniguchi 2000 T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma Nature (Lond) 408 600 605
62. JL Moreno M Kaczmarek AD Keegan M Tondravi 2003 IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL Blood 102 1078 1086
63. E Abe RC Marians W Yu XB Wu T Ando Y Li J Iqbal L Eldeiry G Rajendren HC Blair TF Davies M Zaidi 2003 TSH is a negative regulator of skeletal remodeling Cell 115 151 162